Automatic Implantable Cardioverter-Defibrillator: Techniques of Implantation and Results

Richard J. Thurer; Richard M. Luceri; Hooshang Bolooki

doi:10.1016/S0003-4975(10)60507-3

Automatic Implantable Cardioverter-Defibrillator: Techniques of Implantation and Results

Richard J. Thurer, Richard M. Luceri, Hooshang Bolooki

Surgery

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Abstract

An initial experience with use of the automatic implantable cardioverter-defibrillator (AICD) is described. Twelve patients received the device. One death has occurred during a mean follow-up of 15 months, and it was due to causes other than arrhythmias. Appropriate device discharge terminating a malignant arrhythmia occurred in 9 patients (75%). The observed survival (92%) far exceeds that to be expected in survivors of sudden death treated by conventional means. There have been no operative deaths. Morbidity has been minimal, although three reoperations were required in 2 patients because of lead dislodgment. The AICD has been demonstrated to be effective in treating patients at risk for sudden arrhythmic death. It can be employed safely with minimum morbidity using a variety of implantation techniques.

Original language	English (US)
Pages (from-to)	143-147
Number of pages	5
Journal	Annals of Thoracic Surgery
Volume	42
Issue number	2
DOIs	https://doi.org/10.1016/S0003-4975(10)60507-3
State	Published - Jan 1 1986

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0003-4975(10)60507-3

Fingerprint Dive into the research topics of 'Automatic Implantable Cardioverter-Defibrillator: Techniques of Implantation and Results'. Together they form a unique fingerprint.

Cite this

@article{b93fd0de1ac34ce590607e13be252daa,

title = "Automatic Implantable Cardioverter-Defibrillator: Techniques of Implantation and Results",

abstract = "An initial experience with use of the automatic implantable cardioverter-defibrillator (AICD) is described. Twelve patients received the device. One death has occurred during a mean follow-up of 15 months, and it was due to causes other than arrhythmias. Appropriate device discharge terminating a malignant arrhythmia occurred in 9 patients (75%). The observed survival (92%) far exceeds that to be expected in survivors of sudden death treated by conventional means. There have been no operative deaths. Morbidity has been minimal, although three reoperations were required in 2 patients because of lead dislodgment. The AICD has been demonstrated to be effective in treating patients at risk for sudden arrhythmic death. It can be employed safely with minimum morbidity using a variety of implantation techniques.",

author = "Thurer, {Richard J.} and Luceri, {Richard M.} and Hooshang Bolooki",

year = "1986",

month = jan,

day = "1",

doi = "10.1016/S0003-4975(10)60507-3",

language = "English (US)",

volume = "42",

pages = "143--147",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "2",

}

TY - JOUR

T1 - Automatic Implantable Cardioverter-Defibrillator

T2 - Techniques of Implantation and Results

AU - Thurer, Richard J.

AU - Luceri, Richard M.

AU - Bolooki, Hooshang

PY - 1986/1/1

Y1 - 1986/1/1

N2 - An initial experience with use of the automatic implantable cardioverter-defibrillator (AICD) is described. Twelve patients received the device. One death has occurred during a mean follow-up of 15 months, and it was due to causes other than arrhythmias. Appropriate device discharge terminating a malignant arrhythmia occurred in 9 patients (75%). The observed survival (92%) far exceeds that to be expected in survivors of sudden death treated by conventional means. There have been no operative deaths. Morbidity has been minimal, although three reoperations were required in 2 patients because of lead dislodgment. The AICD has been demonstrated to be effective in treating patients at risk for sudden arrhythmic death. It can be employed safely with minimum morbidity using a variety of implantation techniques.

AB - An initial experience with use of the automatic implantable cardioverter-defibrillator (AICD) is described. Twelve patients received the device. One death has occurred during a mean follow-up of 15 months, and it was due to causes other than arrhythmias. Appropriate device discharge terminating a malignant arrhythmia occurred in 9 patients (75%). The observed survival (92%) far exceeds that to be expected in survivors of sudden death treated by conventional means. There have been no operative deaths. Morbidity has been minimal, although three reoperations were required in 2 patients because of lead dislodgment. The AICD has been demonstrated to be effective in treating patients at risk for sudden arrhythmic death. It can be employed safely with minimum morbidity using a variety of implantation techniques.

UR - http://www.scopus.com/inward/record.url?scp=0022471018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022471018&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(10)60507-3

DO - 10.1016/S0003-4975(10)60507-3

M3 - Article

C2 - 3741011

AN - SCOPUS:0022471018

VL - 42

SP - 143

EP - 147

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -